Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 149

1.

Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome.

Chen YH, Grigelioniene G, Newton PT, Gullander J, Elfving M, Hammarsjö A, Batkovskyte D, Alsaif HS, Kurdi WIY, Abdulwahab F, Shanmugasundaram V, Devey L, Bacrot S, Brodszki J, Huber C, Hamel B, Gisselsson D, Papadogiannakis N, Jedrycha K, Gürtl-Lackner B, Chagin AS, Nishimura G, Aschenbrenner D, Alkuraya FS, Laurence A, Cormier-Daire V, Uhlig HH.

J Exp Med. 2020 Mar 2;217(3). pii: e20191306. doi: 10.1084/jem.20191306.

PMID:
31914175
2.

First Drug Approved for Rare Lung Disease.

Aschenbrenner DS.

Am J Nurs. 2020 Jan;120(1):25-26. doi: 10.1097/01.NAJ.0000652012.36533.27. No abstract available.

PMID:
31880703
3.

New Drug for Type 2 Diabetes.

Aschenbrenner DS.

Am J Nurs. 2020 Jan;120(1):25. doi: 10.1097/01.NAJ.0000652008.98414.51. No abstract available.

PMID:
31880702
4.

Hepatitis C and Compensated Cirrhosis Drug Approved for Eight-Week Treatment.

Aschenbrenner DS.

Am J Nurs. 2020 Jan;120(1):24-25. doi: 10.1097/01.NAJ.0000652004.90791.e9. No abstract available.

PMID:
31880701
5.

New Drug Targets Key Genetic Driver of Cancer.

Aschenbrenner DS.

Am J Nurs. 2019 Dec;119(12):21. doi: 10.1097/01.NAJ.0000615768.79290.14. No abstract available.

PMID:
31764046
6.

New Antibiotic for Community-Acquired Bacterial Pneumonia.

Aschenbrenner DS.

Am J Nurs. 2019 Dec;119(12):20-21. doi: 10.1097/01.NAJ.0000615764.71666.f0. No abstract available.

PMID:
31764045
7.

Parkinson's Drug Doesn't Increase Prostate Cancer Risk.

Aschenbrenner DS.

Am J Nurs. 2019 Dec;119(12):20. doi: 10.1097/01.NAJ.0000615760.33548.62. No abstract available.

PMID:
31764044
8.

New Esophageal Cancer Indication for Pembrolizumab.

Aschenbrenner DS.

Am J Nurs. 2019 Nov;119(11):21. doi: 10.1097/01.NAJ.0000605336.53650.b6. No abstract available.

PMID:
31651493
9.

New Drug for Prostate Cancer.

Aschenbrenner DS.

Am J Nurs. 2019 Nov;119(11):21. doi: 10.1097/01.NAJ.0000605332.46027.7c. No abstract available.

PMID:
31651492
10.

Tofacitinib Receives New Boxed Safety Warning.

Aschenbrenner DS.

Am J Nurs. 2019 Nov;119(11):20. doi: 10.1097/01.NAJ.0000605328.68897.ed. No abstract available.

PMID:
31651491
11.

New Drug Indications for Pediatric Type 2 Diabetes, Cystic Fibrosis, and Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia.

Aschenbrenner DS.

Am J Nurs. 2019 Oct;119(10):23. doi: 10.1097/01.NAJ.0000586152.18638.5b. No abstract available.

PMID:
31567247
12.

New Pediatric Indication for Dalteparin Sodium.

Aschenbrenner DS.

Am J Nurs. 2019 Oct;119(10):22. doi: 10.1097/01.NAJ.0000586148.11015.7e. No abstract available.

PMID:
31567246
13.

Dupilumab Approved to Treat Chronic Rhinosinusitis with Nasal Polyposis.

Aschenbrenner DS.

Am J Nurs. 2019 Oct;119(10):21-22. doi: 10.1097/01.NAJ.0000586144.72896.a5. No abstract available.

PMID:
31567245
14.

New Drug for Hypoactive Sexual Desire Disorder in Premenopausal Women.

Aschenbrenner DS.

Am J Nurs. 2019 Oct;119(10):21. doi: 10.1097/01.NAJ.0000586140.72896.b0. No abstract available.

PMID:
31567244
15.

First Drug Approved for Children with Rare Autoimmune Disorder.

Aschenbrenner DS.

Am J Nurs. 2019 Sep;119(9):23. doi: 10.1097/01.NAJ.0000580248.33784.dd. No abstract available.

PMID:
31449118
16.

New Drugs Treat Rare Heart Disease Caused by Transthyretin-Mediated Amyloidosis.

Aschenbrenner DS.

Am J Nurs. 2019 Sep;119(9):22-23. doi: 10.1097/01.NAJ.0000580244.26161.f0. No abstract available.

PMID:
31449117
17.

New Drug for Breast Cancer with Specific Genetic Mutations.

Aschenbrenner DS.

Am J Nurs. 2019 Sep;119(9):22. doi: 10.1097/01.NAJ.0000580240.24375.b0. No abstract available.

PMID:
31449116
18.

3D Printed Lab-on-a-Chip Platform for Chemical Stimulation and Parallel Analysis of Ion Channel Function.

Aschenbrenner D, Friedrich O, Gilbert DF.

Micromachines (Basel). 2019 Aug 19;10(8). pii: E548. doi: 10.3390/mi10080548.

19.

Opioid-Dependent Patients Require Slow Tapering Of Drug Dose.

Aschenbrenner DS.

Am J Nurs. 2019 Aug;119(8):23. doi: 10.1097/01.NAJ.0000577428.39233.08. No abstract available.

PMID:
31356325
20.

First Oral Testosterone Product Now Available.

Aschenbrenner DS.

Am J Nurs. 2019 Aug;119(8):22-23. doi: 10.1097/01.NAJ.0000577424.31609.23. No abstract available.

PMID:
31356324

Supplemental Content

Loading ...
Support Center